PDB Short entry for 3OW4 HEADER TRANSFERASE/TRANSFERASE INHIBITOR 17-SEP-10 3OW4 TITLE DISCOVERY OF DIHYDROTHIENO- AND DIHYDROFUROPYRIMIDINES AS POTENT PAN TITLE 2 AKT INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: RAC-PK-ALPHA, PROTEIN KINASE B, PKB, PROTO-ONCOGENE C-AKT; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: GSK 3 BETA PEPTIDE; COMPND 10 CHAIN: C, D; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKT1, PKB, RAC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES KEYWDS SERINE-THREONINE KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.DIZON,W.WU,G.P.A.VIGERS,B.J.BRANDHUBER REVDAT 2 24-NOV-10 3OW4 1 JRNL REVDAT 1 10-NOV-10 3OW4 0 JRNL AUTH J.R.BENCSIK,D.XIAO,J.F.BLAKE,N.C.KALLAN,I.S.MITCHELL, JRNL AUTH 2 K.L.SPENCER,R.XU,S.L.GLOOR,M.MARTINSON,T.RISOM,R.D.WOESSNER, JRNL AUTH 3 F.DIZON,W.I.WU,G.P.VIGERS,B.J.BRANDHUBER,N.J.SKELTON, JRNL AUTH 4 W.W.PRIOR,L.J.MURRAY JRNL TITL DISCOVERY OF DIHYDROTHIENO- AND DIHYDROFUROPYRIMIDINES AS JRNL TITL 2 POTENT PAN AKT INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 20 7037 2010 JRNL REFN ISSN 0960-894X JRNL PMID 20971641 JRNL DOI 10.1016/J.BMCL.2010.09.112 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.47 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 86.3 REMARK 3 NUMBER OF REFLECTIONS : 22769 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.268 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1110 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 832 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.00 REMARK 3 BIN R VALUE (WORKING SET) : 0.1990 REMARK 3 BIN FREE R VALUE SET COUNT : 46 REMARK 3 BIN FREE R VALUE : 0.3090 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5366 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 60 REMARK 3 SOLVENT ATOMS : 171 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.81000 REMARK 3 B22 (A**2) : 0.06000 REMARK 3 B33 (A**2) : -0.33000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.11000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.360 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.230 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.297 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.938 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.867 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5562 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7492 ; 1.665 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 650 ; 6.719 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 270 ;37.403 ;23.333 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 994 ;19.501 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 40 ;20.625 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 776 ; 0.106 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4238 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3258 ; 0.706 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5242 ; 1.376 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2304 ; 1.991 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2250 ; 3.338 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3OW4 COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-SEP-10. REMARK 100 THE RCSB ID CODE IS RCSB061645. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-MAY-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : CONFOCAL MIRRORS REMARK 200 OPTICS : OSMIC CONFOCAL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22796 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.7 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : 0.04300 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 16.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 50.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.70 REMARK 200 R MERGE FOR SHELL (I) : 0.10700 REMARK 200 R SYM FOR SHELL (I) : 0.08400 REMARK 200 <I/SIGMA(I)> FOR SHELL : 8.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.32 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8.3 MG/ML AKT1 PROTEIN, PREINCUBATED REMARK 280 WITH 0.6 MM GSK3B PEPTIDE, 5 MM MN-AMP-PNP. THE PRECIPITANT WAS REMARK 280 20% PEG 4K, 15% ISOPROPANOL, 100 MM HEPES, PH 7.5, UNDER OIL, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 27.91150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15220 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 140 REMARK 465 ALA A 141 REMARK 465 MET A 142 REMARK 465 ALA A 143 REMARK 465 ILE A 449 REMARK 465 THR A 450 REMARK 465 PRO A 451 REMARK 465 PRO A 452 REMARK 465 ASP A 453 REMARK 465 GLN A 454 REMARK 465 ASP A 455 REMARK 465 ASP A 456 REMARK 465 SER A 457 REMARK 465 MET A 458 REMARK 465 GLU A 459 REMARK 465 CYS A 460 REMARK 465 VAL A 461 REMARK 465 ASP A 462 REMARK 465 SER A 463 REMARK 465 GLU A 464 REMARK 465 ARG A 465 REMARK 465 THR A 479 REMARK 465 ALA A 480 REMARK 465 GLY B 140 REMARK 465 ALA B 141 REMARK 465 MET B 142 REMARK 465 ALA B 143 REMARK 465 ILE B 449 REMARK 465 THR B 450 REMARK 465 PRO B 451 REMARK 465 PRO B 452 REMARK 465 ASP B 453 REMARK 465 GLN B 454 REMARK 465 ASP B 455 REMARK 465 ASP B 456 REMARK 465 SER B 457 REMARK 465 MET B 458 REMARK 465 GLU B 459 REMARK 465 CYS B 460 REMARK 465 VAL B 461 REMARK 465 ASP B 462 REMARK 465 SER B 463 REMARK 465 GLU B 464 REMARK 465 ARG B 465 REMARK 465 THR B 479 REMARK 465 ALA B 480 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 204 60.80 -116.95 REMARK 500 PRO A 208 -38.88 -36.76 REMARK 500 SER A 240 -40.33 -29.72 REMARK 500 ARG A 243 -57.24 79.08 REMARK 500 ARG A 273 -8.21 69.67 REMARK 500 ASP A 292 82.83 79.63 REMARK 500 ASP A 302 -122.42 0.33 REMARK 500 ASP A 398 -136.68 60.76 REMARK 500 PHE A 425 111.07 -161.84 REMARK 500 SER A 431 -112.49 -127.83 REMARK 500 GLU A 432 -29.30 -146.57 REMARK 500 ALA A 444 57.48 -92.28 REMARK 500 GLN A 471 23.23 46.57 REMARK 500 SER A 477 150.11 -44.84 REMARK 500 LYS B 158 -147.95 -93.17 REMARK 500 LYS B 214 -65.23 -91.72 REMARK 500 THR B 219 -159.67 -126.66 REMARK 500 ARG B 243 -47.36 77.19 REMARK 500 ARG B 273 -19.31 77.32 REMARK 500 ASP B 292 94.72 74.64 REMARK 500 ASP B 302 -139.37 48.90 REMARK 500 ASN B 324 -160.21 -79.78 REMARK 500 ALA B 329 -6.15 -59.55 REMARK 500 LEU B 384 34.27 -99.72 REMARK 500 ASP B 398 -121.27 71.77 REMARK 500 PHE B 408 30.40 -97.55 REMARK 500 THR B 430 -81.84 -65.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SMY A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SMY B 2 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3OW3 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THERE IS A GLY -> SER SEQUENCE CONFLICT AT RESIDUE 478 IN UNIPROT REMARK 999 SEQUENCE DATABASE. DBREF 3OW4 A 144 480 UNP P31749 AKT1_HUMAN 144 480 DBREF 3OW4 B 144 480 UNP P31749 AKT1_HUMAN 144 480 DBREF 3OW4 C 1 10 PDB 3OW4 3OW4 1 10 DBREF 3OW4 D 1 10 PDB 3OW4 3OW4 1 10 SEQADV 3OW4 GLY A 140 UNP P31749 EXPRESSION TAG SEQADV 3OW4 ALA A 141 UNP P31749 EXPRESSION TAG SEQADV 3OW4 MET A 142 UNP P31749 EXPRESSION TAG SEQADV 3OW4 ALA A 143 UNP P31749 EXPRESSION TAG SEQADV 3OW4 ASP A 473 UNP P31749 SER 473 ENGINEERED MUTATION SEQADV 3OW4 SER A 478 UNP P31749 GLY 478 SEE REMARK 999 SEQADV 3OW4 GLY B 140 UNP P31749 EXPRESSION TAG SEQADV 3OW4 ALA B 141 UNP P31749 EXPRESSION TAG SEQADV 3OW4 MET B 142 UNP P31749 EXPRESSION TAG SEQADV 3OW4 ALA B 143 UNP P31749 EXPRESSION TAG SEQADV 3OW4 ASP B 473 UNP P31749 SER 473 ENGINEERED MUTATION SEQADV 3OW4 SER B 478 UNP P31749 GLY 478 SEE REMARK 999 SEQRES 1 A 341 GLY ALA MET ALA ARG VAL THR MET ASN GLU PHE GLU TYR SEQRES 2 A 341 LEU LYS LEU LEU GLY LYS GLY THR PHE GLY LYS VAL ILE SEQRES 3 A 341 LEU VAL LYS GLU LYS ALA THR GLY ARG TYR TYR ALA MET SEQRES 4 A 341 LYS ILE LEU LYS LYS GLU VAL ILE VAL ALA LYS ASP GLU SEQRES 5 A 341 VAL ALA HIS THR LEU THR GLU ASN ARG VAL LEU GLN ASN SEQRES 6 A 341 SER ARG HIS PRO PHE LEU THR ALA LEU LYS TYR SER PHE SEQRES 7 A 341 GLN THR HIS ASP ARG LEU CYS PHE VAL MET GLU TYR ALA SEQRES 8 A 341 ASN GLY GLY GLU LEU PHE PHE HIS LEU SER ARG GLU ARG SEQRES 9 A 341 VAL PHE SER GLU ASP ARG ALA ARG PHE TYR GLY ALA GLU SEQRES 10 A 341 ILE VAL SER ALA LEU ASP TYR LEU HIS SER GLU LYS ASN SEQRES 11 A 341 VAL VAL TYR ARG ASP LEU LYS LEU GLU ASN LEU MET LEU SEQRES 12 A 341 ASP LYS ASP GLY HIS ILE LYS ILE THR ASP PHE GLY LEU SEQRES 13 A 341 CYS LYS GLU GLY ILE LYS ASP GLY ALA THR MET LYS TPO SEQRES 14 A 341 PHE CYS GLY THR PRO GLU TYR LEU ALA PRO GLU VAL LEU SEQRES 15 A 341 GLU ASP ASN ASP TYR GLY ARG ALA VAL ASP TRP TRP GLY SEQRES 16 A 341 LEU GLY VAL VAL MET TYR GLU MET MET CYS GLY ARG LEU SEQRES 17 A 341 PRO PHE TYR ASN GLN ASP HIS GLU LYS LEU PHE GLU LEU SEQRES 18 A 341 ILE LEU MET GLU GLU ILE ARG PHE PRO ARG THR LEU GLY SEQRES 19 A 341 PRO GLU ALA LYS SER LEU LEU SER GLY LEU LEU LYS LYS SEQRES 20 A 341 ASP PRO LYS GLN ARG LEU GLY GLY GLY SER GLU ASP ALA SEQRES 21 A 341 LYS GLU ILE MET GLN HIS ARG PHE PHE ALA GLY ILE VAL SEQRES 22 A 341 TRP GLN HIS VAL TYR GLU LYS LYS LEU SER PRO PRO PHE SEQRES 23 A 341 LYS PRO GLN VAL THR SER GLU THR ASP THR ARG TYR PHE SEQRES 24 A 341 ASP GLU GLU PHE THR ALA GLN MET ILE THR ILE THR PRO SEQRES 25 A 341 PRO ASP GLN ASP ASP SER MET GLU CYS VAL ASP SER GLU SEQRES 26 A 341 ARG ARG PRO HIS PHE PRO GLN PHE ASP TYR SER ALA SER SEQRES 27 A 341 SER THR ALA SEQRES 1 B 341 GLY ALA MET ALA ARG VAL THR MET ASN GLU PHE GLU TYR SEQRES 2 B 341 LEU LYS LEU LEU GLY LYS GLY THR PHE GLY LYS VAL ILE SEQRES 3 B 341 LEU VAL LYS GLU LYS ALA THR GLY ARG TYR TYR ALA MET SEQRES 4 B 341 LYS ILE LEU LYS LYS GLU VAL ILE VAL ALA LYS ASP GLU SEQRES 5 B 341 VAL ALA HIS THR LEU THR GLU ASN ARG VAL LEU GLN ASN SEQRES 6 B 341 SER ARG HIS PRO PHE LEU THR ALA LEU LYS TYR SER PHE SEQRES 7 B 341 GLN THR HIS ASP ARG LEU CYS PHE VAL MET GLU TYR ALA SEQRES 8 B 341 ASN GLY GLY GLU LEU PHE PHE HIS LEU SER ARG GLU ARG SEQRES 9 B 341 VAL PHE SER GLU ASP ARG ALA ARG PHE TYR GLY ALA GLU SEQRES 10 B 341 ILE VAL SER ALA LEU ASP TYR LEU HIS SER GLU LYS ASN SEQRES 11 B 341 VAL VAL TYR ARG ASP LEU LYS LEU GLU ASN LEU MET LEU SEQRES 12 B 341 ASP LYS ASP GLY HIS ILE LYS ILE THR ASP PHE GLY LEU SEQRES 13 B 341 CYS LYS GLU GLY ILE LYS ASP GLY ALA THR MET LYS TPO SEQRES 14 B 341 PHE CYS GLY THR PRO GLU TYR LEU ALA PRO GLU VAL LEU SEQRES 15 B 341 GLU ASP ASN ASP TYR GLY ARG ALA VAL ASP TRP TRP GLY SEQRES 16 B 341 LEU GLY VAL VAL MET TYR GLU MET MET CYS GLY ARG LEU SEQRES 17 B 341 PRO PHE TYR ASN GLN ASP HIS GLU LYS LEU PHE GLU LEU SEQRES 18 B 341 ILE LEU MET GLU GLU ILE ARG PHE PRO ARG THR LEU GLY SEQRES 19 B 341 PRO GLU ALA LYS SER LEU LEU SER GLY LEU LEU LYS LYS SEQRES 20 B 341 ASP PRO LYS GLN ARG LEU GLY GLY GLY SER GLU ASP ALA SEQRES 21 B 341 LYS GLU ILE MET GLN HIS ARG PHE PHE ALA GLY ILE VAL SEQRES 22 B 341 TRP GLN HIS VAL TYR GLU LYS LYS LEU SER PRO PRO PHE SEQRES 23 B 341 LYS PRO GLN VAL THR SER GLU THR ASP THR ARG TYR PHE SEQRES 24 B 341 ASP GLU GLU PHE THR ALA GLN MET ILE THR ILE THR PRO SEQRES 25 B 341 PRO ASP GLN ASP ASP SER MET GLU CYS VAL ASP SER GLU SEQRES 26 B 341 ARG ARG PRO HIS PHE PRO GLN PHE ASP TYR SER ALA SER SEQRES 27 B 341 SER THR ALA SEQRES 1 C 10 GLY ARG PRO ARG THR THR SER PHE ALA GLU SEQRES 1 D 10 GLY ARG PRO ARG THR THR SER PHE ALA GLU MODRES 3OW4 TPO A 308 THR PHOSPHOTHREONINE MODRES 3OW4 TPO B 308 THR PHOSPHOTHREONINE HET TPO A 308 11 HET TPO B 308 11 HET SMY A 1 30 HET SMY B 2 30 HETNAM TPO PHOSPHOTHREONINE HETNAM SMY (2R)-3-(1H-INDOL-3-YL)-1-{4-[(5S)-5-METHYL-5,7- HETNAM 2 SMY DIHYDROTHIENO[3,4-D]PYRIMIDIN-4-YL]PIPERAZIN-1-YL}-1- HETNAM 3 SMY OXOPROPAN-2-AMINE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 SMY 2(C22 H26 N6 O S) FORMUL 7 HOH *171(H2 O) HELIX 1 1 THR A 146 ASN A 148 5 3 HELIX 2 2 LYS A 183 LYS A 189 1 7 HELIX 3 3 GLU A 191 ASN A 204 1 14 HELIX 4 4 GLU A 234 ARG A 243 1 10 HELIX 5 5 SER A 246 GLU A 267 1 22 HELIX 6 6 LYS A 276 GLU A 278 5 3 HELIX 7 7 THR A 312 LEU A 316 5 5 HELIX 8 8 ALA A 317 GLU A 322 1 6 HELIX 9 9 ALA A 329 GLY A 345 1 17 HELIX 10 10 ASP A 353 GLU A 364 1 12 HELIX 11 11 GLY A 373 LEU A 384 1 12 HELIX 12 12 ASP A 387 ARG A 391 5 5 HELIX 13 13 ASP A 398 GLN A 404 1 7 HELIX 14 14 HIS A 405 ALA A 409 5 5 HELIX 15 15 VAL A 412 GLU A 418 1 7 HELIX 16 16 ASP A 439 ALA A 444 1 6 HELIX 17 17 THR B 146 ASN B 148 5 3 HELIX 18 18 LYS B 183 LYS B 189 1 7 HELIX 19 19 GLU B 191 ASN B 204 1 14 HELIX 20 20 GLU B 234 ARG B 243 1 10 HELIX 21 21 SER B 246 GLU B 267 1 22 HELIX 22 22 LYS B 276 GLU B 278 5 3 HELIX 23 23 THR B 312 LEU B 316 5 5 HELIX 24 24 ALA B 317 ASP B 323 1 7 HELIX 25 25 ALA B 329 GLY B 345 1 17 HELIX 26 26 ASP B 353 GLU B 364 1 12 HELIX 27 27 GLY B 373 LEU B 384 1 12 HELIX 28 28 ASP B 387 ARG B 391 5 5 HELIX 29 29 ASP B 398 GLN B 404 1 7 HELIX 30 30 HIS B 405 ALA B 409 5 5 HELIX 31 31 VAL B 412 LYS B 419 1 8 HELIX 32 32 ASP B 439 ALA B 444 1 6 SHEET 1 A 6 PHE A 150 GLY A 159 0 SHEET 2 A 6 GLY A 162 GLU A 169 -1 O VAL A 164 N LEU A 156 SHEET 3 A 6 TYR A 175 LYS A 182 -1 O TYR A 176 N VAL A 167 SHEET 4 A 6 ARG A 222 GLU A 228 -1 O MET A 227 N ALA A 177 SHEET 5 A 6 LEU A 213 GLN A 218 -1 N LYS A 214 O VAL A 226 SHEET 6 A 6 TYR A 474 SER A 475 -1 O TYR A 474 N SER A 216 SHEET 1 B 2 LEU A 280 LEU A 282 0 SHEET 2 B 2 ILE A 288 ILE A 290 -1 O LYS A 289 N MET A 281 SHEET 1 C 2 CYS A 310 GLY A 311 0 SHEET 2 C 2 PHE C 8 ALA C 9 -1 O PHE C 8 N GLY A 311 SHEET 1 D 6 PHE B 150 GLY B 157 0 SHEET 2 D 6 GLY B 162 GLU B 169 -1 O LYS B 168 N GLU B 151 SHEET 3 D 6 TYR B 175 LYS B 182 -1 O TYR B 176 N VAL B 167 SHEET 4 D 6 ARG B 222 GLU B 228 -1 O MET B 227 N ALA B 177 SHEET 5 D 6 LEU B 213 GLN B 218 -1 N TYR B 215 O VAL B 226 SHEET 6 D 6 TYR B 474 SER B 475 -1 O TYR B 474 N SER B 216 SHEET 1 E 2 LEU B 280 LEU B 282 0 SHEET 2 E 2 ILE B 288 ILE B 290 -1 O LYS B 289 N MET B 281 SHEET 1 F 2 CYS B 310 GLY B 311 0 SHEET 2 F 2 PHE D 8 ALA D 9 -1 O PHE D 8 N GLY B 311 LINK C LYS A 307 N TPO A 308 1555 1555 1.34 LINK C TPO A 308 N PHE A 309 1555 1555 1.34 LINK C LYS B 307 N TPO B 308 1555 1555 1.34 LINK C TPO B 308 N PHE B 309 1555 1555 1.33 SITE 1 AC1 12 HOH A 124 LEU A 156 GLY A 157 GLY A 162 SITE 2 AC1 12 VAL A 164 GLU A 228 ALA A 230 GLU A 234 SITE 3 AC1 12 MET A 281 THR A 291 PHE A 438 ARG C 4 SITE 1 AC2 12 LEU B 156 GLY B 157 LYS B 158 GLY B 162 SITE 2 AC2 12 ALA B 177 LYS B 179 GLU B 228 ALA B 230 SITE 3 AC2 12 GLU B 234 THR B 291 PHE B 438 ARG D 4 CRYST1 86.427 55.823 91.354 90.00 103.93 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011570 0.000000 0.002869 0.00000 SCALE2 0.000000 0.017914 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011278 0.00000